Joel G Winner

1.2k total citations
13 papers, 822 citations indexed

About

Joel G Winner is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Joel G Winner has authored 13 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 6 papers in Pharmacology. Recurrent topics in Joel G Winner's work include Pharmacogenetics and Drug Metabolism (8 papers), Treatment of Major Depression (6 papers) and Tryptophan and brain disorders (4 papers). Joel G Winner is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Treatment of Major Depression (6 papers) and Tryptophan and brain disorders (4 papers). Joel G Winner collaborates with scholars based in United States and India. Joel G Winner's co-authors include Josiah D. Allen, C. Anthony Altar, Joseph Carhart, Bryan Dechairo, Daniel K. Hall‐Flavin, David A. Mrazek, Maureen S. Drews, Karen Snyder, Jennifer R. Geske and J. Jordan and has published in prestigious journals such as Translational Psychiatry, Current Medical Research and Opinion and Pharmacogenetics and Genomics.

In The Last Decade

Joel G Winner

13 papers receiving 751 citations

Peers

Joel G Winner
Josiah D. Allen United States
Joseph Carhart United States
Maureen S. Drews United States
Karen Snyder United States
Jacob T. Brown United States
Lawrence J. Albers United States
Josiah D. Allen United States
Joel G Winner
Citations per year, relative to Joel G Winner Joel G Winner (= 1×) peers Josiah D. Allen

Countries citing papers authored by Joel G Winner

Since Specialization
Citations

This map shows the geographic impact of Joel G Winner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel G Winner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel G Winner more than expected).

Fields of papers citing papers by Joel G Winner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel G Winner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel G Winner. The network helps show where Joel G Winner may publish in the future.

Co-authorship network of co-authors of Joel G Winner

This figure shows the co-authorship network connecting the top 25 collaborators of Joel G Winner. A scholar is included among the top collaborators of Joel G Winner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel G Winner. Joel G Winner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jablonski, Michael, Nina King, Yongbao Wang, et al.. (2018). Analytical Validation of a Psychiatric Pharmacogenomic Test. Personalized Medicine. 15(3). 189–197. 26 indexed citations
2.
Lorenz, Raymond A., et al.. (2016). Use of combinatorial pharmacogenomic testing in two cases from community psychiatry. Pharmacogenomics and Personalized Medicine. Volume 9. 79–84. 5 indexed citations
3.
Altar, C. Anthony, Joseph Carhart, Josiah D. Allen, et al.. (2015). Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. The Pharmacogenomics Journal. 15(5). 443–451. 84 indexed citations
4.
Jablonski, Michael, et al.. (2015). The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes. PubMed. 5. 47–49. 16 indexed citations
5.
Altar, C. Anthony, Joseph Carhart, Josiah D. Allen, et al.. (2015). Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies. PubMed. 1(3). 145–155. 55 indexed citations
6.
Winner, Joel G, Joseph Carhart, C. Anthony Altar, et al.. (2015). Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Current Medical Research and Opinion. 31(9). 1633–1643. 81 indexed citations
7.
Winner, Joel G & Bryan Dechairo. (2015). Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.. PubMed. 88(4). 375–82. 14 indexed citations
8.
Winner, Joel G, Joseph Carhart, C. Anthony Altar, Josiah D. Allen, & Bryan Dechairo. (2013). A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.. PubMed. 16(89). 219–27. 138 indexed citations
9.
Winner, Joel G, et al.. (2013). Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Translational Psychiatry. 3(3). e242–e242. 95 indexed citations
10.
Hall‐Flavin, Daniel K., Joel G Winner, Josiah D. Allen, et al.. (2013). Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenetics and Genomics. 23(10). 535–548. 148 indexed citations
11.
Winner, Joel G. (2012). Overwhelmed by Side Effects. Current psychiatry. 11(6). 54. 1 indexed citations
12.
Hall‐Flavin, Daniel K., Joel G Winner, Josiah D. Allen, et al.. (2012). Using a pharmacogenomic algorithm to guide the treatment of depression. Translational Psychiatry. 2(10). e172–e172. 143 indexed citations
13.
Winner, Joel G, Deborah Goebert, Courtenay Matsu, & David A. Mrazek. (2010). Training in Psychiatric Genomics During Residency: A New Challenge. Academic Psychiatry. 34(2). 115–118. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026